Fat Embolism Clinical Presentation
- Author: Lisa Kirkland, MD, FACP, CNSP, MSHA; Chief Editor: Vincent Lopez Rowe, MD more...
History
- Trauma to long bone or pelvis, including orthopedic procedures
- Parenteral lipid infusion
- Recent corticosteroid administration
Physical
Respiratory symptoms, signs of radiologic disease; cerebral signs without other etiologies; and petechial rash are the major criteria. A pulse that is over 110 beats per minute, fever over 38.5 º C, retinal changes of fat globules or petechiae, renal dysfunction, jaundice, acute drop in hemoglobin and/or platelets, and elevated sedimentation rate are the minor criteria. One major and 4 minor criteria, plus fat microglobulinemia, must be present to formally diagnose fat embolism syndrome.
- Cardiopulmonary
- Early persistent tachycardia may herald the onset of the syndrome.
- Patients become tachypneic, dyspneic, and hypoxic due to ventilation-perfusion abnormalities 12-72 hours after injury.
- Patients become febrile with high-spiking temperatures.
- Dermatologic
- Alert clinicians may notice reddish-brown nonpalpable petechiae developing over the upper body, particularly in the axillae, within 24-36 hours of insult or injury. These petechiae occur in only 20-50% of patients and resolve quickly, but they are virtually diagnostic in the right clinical setting.
- Subconjunctival and oral hemorrhages and petechiae also appear.
Causes
- Blunt trauma (associated with 90% of all cases)
- Acute pancreatitis
- Burns
- Joint reconstruction
- Liposuction
- Cardiopulmonary bypass
- Decompression sickness
- Parenteral lipid infusion
- Sickle cell crisis[3, 4]
- Pathologic fractures
Schnaid E, Lamprey JM, Viljoen MJ, Joffe BI, Seftel HC. The early biochemical and hormonal profile of patients with long bone fractures at risk of fat embolism syndrome. J Trauma. Mar 1987;27(3):309-11. [Medline].
Metting Z, Rödiger LA, Regtien JG, van der Naalt J. Delayed coma in head injury: consider cerebral fat embolism. Clin Neurol Neurosurg. Sep 2009;111(7):597-600. [Medline].
Godeau B, Schaeffer A, Bachir D, Fleury-Feith J, Galacteros F, Verra F. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med. May 1996;153(5):1691-6. [Medline].
Shapiro MP, Hayes JA. Fat embolism in sickle cell disease. Report of a case with brief review of the literature. Arch Intern Med. Jan 1984;144(1):181-2. [Medline].
Gallardo X, CastanerE, Mata JM. Nodular pattern at Lung Computed Tomography in Fat Embolism Syndrome: A Helpful Finding. J Computer Assisted Tomography. 2006;30:254-7.
Stoeger A, Daniaux M, Felber S, Stockhammer G, Aichner F, zur Nedden D. MRI findings in cerebral fat embolism. Eur Radiol. 1998;8(9):1590-3. [Medline].
Forteza AM, Koch S, Romano JG, et al. Transcranial doppler detection of fat emboli. Stroke. Dec 1999;30(12):2687-91. [Medline].
Vedrinne JM, Guillaume C, Gagnieu MC, Gratadour P, Fleuret C, Motin J. Bronchoalveolar lavage in trauma patients for diagnosis of fat embolism syndrome. Chest. Nov 1992;102(5):1323-7. [Medline].
Mimoz O, Edouard A, Beydon L, Quillard J, Verra F, Fleury J. Contribution of bronchoalveolar lavage to the diagnosis of posttraumatic pulmonary fat embolism. Intensive Care Med. Dec 1995;21(12):973-80. [Medline].
Wong MW, Tsui HF, Yung SH, Chan KM, Cheng JC. Continuous pulse oximeter monitoring for inapparent hypoxemia after long bone fractures. J Trauma. Feb 2004;56(2):356-62. [Medline].
Alho A, Saikku K, Eerola P, Koskinen M, Hämäläinen M. Corticosteroids in patients with a high risk of fat embolism syndrome. Surg Gynecol Obstet. Sep 1978;147(3):358-62. [Medline].
Byrick RJ, Mullen JB, Wong PY, Wigglesworth D, Kay JC. Corticosteroids do not inhibit acute pulmonary response to fat embolism. Can J Anaesth. May 1990;37(4 Pt 2):S130. [Medline].
Bilgrami S, Hasson J, Tutschka PJ. Case 23-1998: fat embolism. N Engl J Med. Feb 4 1999;340(5):393-4. [Medline].
Estebe JP, Malledant Y. Fat embolism after lipid emulsion infusion. Lancet. Mar 16 1991;337(8742):673. [Medline].
Fabian TC. Unravelling the fat embolism syndrome. N Engl J Med. Sep 23 1993;329(13):961-3. [Medline].
Fabian TC, Hoots AV, Stanford DS, Patterson CR, Mangiante EC. Fat embolism syndrome: prospective evaluation in 92 fracture patients. Crit Care Med. Jan 1990;18(1):42-6. [Medline].
Habashi NM, Andrews PL. Therapeutic Aspects of Fat Embolism Syndrome. Injury. 2006;37(Supplem 4):S68-73.
Hofmann S, Hopf R, Huemer G, Kratochwill C, Koller-Strametz J, Schlag G. [Modified surgical technique for reduction of bone marrow spilling in cement-free hip endoprosthesis]. Orthopade. Apr 1995;24(2):130-7. [Medline].
Kallenbach J, Lewis M, Zaltzman M, Feldman C, Orford A, Zwi S. 'Low-dose' corticosteroid prophylaxis against fat embolism. J Trauma. Oct 1987;27(10):1173-6. [Medline].
Liu HK, Chen WC. Images in clinical medicine. Fat embolism syndrome. N Engl J Med. May 5 2011;364(18):1761. [Medline].
Reider E, Sherman Y, Weiss Y, Liebergall M, Pizov R. Alveolar macrophages fat stain in early diagnosis of fat embolism syndrome. Isr J Med Sci. Oct 1997;33(10):654-8. [Medline].
Schonfeld SA, Ploysongsang Y, DiLisio R, Crissman JD, Miller E, Hammerschmidt DE. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. Oct 1983;99(4):438-43. [Medline].
Scully RE, Mark EJ, McNeely WF. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-1998. Tachypnea, changed mental status, and pancytopenia in an elderly man with treated lymphoma. N Engl J Med. Jul 23 1998;339(4):254-61. [Medline].
Teng QS, Li G, Zhang BX, Zhu XH, Ma CX. Experimental study of early diagnosis and treatment of fat embolism syndrome. J Orthop Trauma. Jun 1995;9(3):183-9. [Medline].
White T, Petrisor BA, Bhandar M. Prevention of Fat Embolism Syndrome. Injury. 2006;37(Supplem 1):S59-67.
| Dose | Model | Timing | Duration of Study | Effect on Disease Incidence |
| 30 mg/kg | Dog | Pre-event | 60 min | None |
| 10 mg/kg q8h for 24 h | Human trauma | At admission | No data | Declining |
| 7.5 mg/kg q6h for 12 h or placebo | Human trauma | Within 12 h | 2 d | Declining |

